This can help in elucidating the association between several molecular levels which enable us to identify the biological relationships and understand the molecular processes driving the cancer.
Here, we provide a comprehensive analysis of triple-negative BC features on several molecular levels in BC cell lines, thereby creating an in-depth resource to access the suitability of individual lines as experimental models for studying BC tumour biology, biomarkers and possible therapeutic targets in the context of preclinical target validation.
Aging affects cardiomyocytes at several subcellular and molecular levels, including alterations at the level of the DNA, increased oxidative stress, changes in gene/protein expression and posttranslational modifications, and the handling of cellular 'waste' material by autophagy [ 13– 15].
Aging affects cardiomyocytes at several subcellular and molecular levels, including alterations in the gene/protein expression and posttranslational modifications such as advanced glycation endproducts and protein oxidation, changes at the DNA level for example mutations and telomere shortening, oxidative stress increase (ROS formation), and decrease of autophagy [ 21].
Although BCR-ABL coordinates several molecular alterations, the STATIP1 protein levels remained unaltered following BCR-ABL inhibition using 1 μM IM for 24 h.
This improved thermotolerance was due to a higher level of several molecular chaperones, as confirmed by transcriptomic and proteomic analysis, and was fully dependent on the transcription factor DAF-16, but less so on HSF-1.
This latter breed was sometimes referred to as a particular longhorn taurine [ 3], however, several molecular analyses showed a high level of Zebu admixture in it [ 4, 10].
We thoroughly examined the underlying mechanisms at cellular and molecular levels and obtained several interesting results that we have presented in this paper.
Moreover, proteasome inhibition with bortezomib alters the binding of other transcription factors to the promoter region of several molecular effectors, thus modulating their expression levels [ 149].
We detected retrieval of several molecular markers at the basal steady-state expression levels (Supplementary Figure S8A).
Several studies have demonstrated that a combination of these two molecular levels may be advantageous for determining robust signatures and clinically relevant molecular classifiers of GBM [ 2, 3].
